The recent identification of mutations in the gene encoding the key epidermal protein filaggrin (FLG) as a remarkably strong and widely replicated risk factor for atopic dermatitis (AD) has led to a new focus on skin barrier deficiency in patients with AD. The gene discussed is FLG; the disease is Alzheimer disease.